Literature DB >> 9920095

Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.

B Zinman1, A J Hanley, S B Harris, J Kwan, I G Fantus.   

Abstract

Recent research suggests that tumor necrosis factor-alpha (TNF alpha) may play an important role in obesity-associated insulin resistance and diabetes. We studied the relationship between TNF alpha and the anthropometric and physiological variables associated with insulin resistance and diabetes in an isolated Native Canadian population with very high rates of type 2 diabetes mellitus (DM). A stratified random sample (n = 80) of participants was selected from a population-based survey designed to determine the prevalence of type 2 DM and its associated risk factors. Fasting blood samples for glucose, insulin, triglyceride, leptin, and TNF alpha were collected; a 75-g oral glucose tolerance test was administered, and a second blood sample was drawn after 120 min. Insulin resistance was estimated using the homeostasis assessment (HOMA) model. Systolic and diastolic blood pressure (BP), height, weight, and waist and hip circumferences were determined, and percent body fat was estimated using biological impedance analysis. The relationship between circulating concentrations of TNF alpha and the other variables was assessed using Spearman correlation coefficients, analysis of covariance, and multiple linear regression. The mean TNF alpha concentration was 5.6 pg/mL (SD = 2.18) and ranged from 2.0-12.9 pg/mL, with no difference between men and women (P = 0.67). There were moderate, but statistically significant, correlations between TNF alpha and fasting insulin, HOMA insulin resistance (HOMA IR) waist circumference, fasting triglyceride, and systolic BP (r = 0.23-0.34; all P < 0.05); in all cases, coefficients for females were stronger than those for males. Individuals with normal glucose tolerance had lower log TNF alpha concentrations than those with impaired glucose tolerance or type 2 DM (both P = 0.03, adjusted for age and sex), although differences were not significant after adjustment for HOMA IR (both P > 0.25). Regression analysis indicated that log HOMA IR and log systolic BP were significant independent contributors to variations in log TNF alpha concentration (model r2 = 0.32). We conclude that in this homogeneous Native Canadian population, circulating TNF alpha concentrations are positively correlated with insulin resistance across a spectrum of glucose tolerance. The data suggest a possible role for TNF alpha in the pathophysiology of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920095     DOI: 10.1210/jcem.84.1.5405

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  56 in total

1.  C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia.

Authors:  S Bo; A Signorile; G Menato; R Gambino; C Bardelli; M L Gallo; M Cassader; M Massobrio; G F Pagano
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes.

Authors:  Lea Duvnjak; Kristina Blaslov; Matea Nikolac Perković; Jadranka Knežević Ćuća
Journal:  Endocrine       Date:  2016-02-23       Impact factor: 3.633

3.  Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.

Authors:  Yang Yu; Yiling Cao; Balyssa Bell; Xiaolei Chen; Robert M Weiss; Robert B Felder; Shun-Guang Wei
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

4.  Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.

Authors:  Martijn van Doorn; Michiel Kemme; Margriet Ouwens; Ewoud J van Hoogdalem; Richard Jones; Hans Romijn; Marieke de Kam; Rik Schoemaker; Koos Burggraaf; Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

5.  Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.

Authors:  H F Escobar-Morreale; G Villuendas; J I Botella-Carretero; J Sancho; J L San Millán
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

6.  Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats.

Authors:  Linda T Tran; Kathleen M MacLeod; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

7.  Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.

Authors:  Eun-Sil Yeo; Ji-Yun Hwang; Ji Eun Park; Young Ju Choi; Kap Bum Huh; Wha Young Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

8.  Stress and body mass index each contributes independently to tumor necrosis factor-alpha production in prepubescent Latino children.

Authors:  Denise Dixon; Hongdao Meng; Ronald Goldberg; Neil Schneiderman; Alan Delamater
Journal:  J Pediatr Nurs       Date:  2008-09-04       Impact factor: 2.145

Review 9.  Is Alzheimer's disease a systemic disease?

Authors:  Jill K Morris; Robyn A Honea; Eric D Vidoni; Russell H Swerdlow; Jeffrey M Burns
Journal:  Biochim Biophys Acta       Date:  2014-04-18

10.  Endocrine and metabolic changes in human aging.

Authors:  W A Banks; J E Morley
Journal:  J Am Aging Assoc       Date:  2000-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.